Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-10-20
pubmed:abstractText
A group of SARS-like coronaviruses (SL-CoV) have been identified in horseshoe bats. Despite SL-CoVs and SARS-CoV share identical genome structure and high-level sequence similarity, SL-CoV does not bind to the same cellular receptor as for SARS-CoV and the N-terminus of the S proteins only share 64% amino acid identity, suggesting there are fundamental differences between these two groups of coronaviruses. To gain insight into the basis of this difference, we established a recombinant adenovirus system expressing the S protein from SL-CoV (rAd-Rp3-S) to investigate its immune characterization. Our results showed that immunized mice generated strong humoral immune responses against the SL-CoV S protein. Moreover, a strong cellular immune response demonstrated by elevated IFN-? and IL-6 levels was also observed in these mice. However, the induced antibody from these mice had weaker cross-reaction with the SARS-CoV S protein, and did not neutralize HIV pseudotyped with SARS-CoV S protein. These results demonstrated that the immunogenicity of the SL-CoV S protein is distinct from that of SARS-CoV, which may cause the immunological differences between human SARS-CoV and bat SL-CoV. Furthermore, the recombinant virus could serve as a potential vaccine candidate against bat SL-CoV infection.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1995-820X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-44
pubmed:meshHeading
pubmed-meshheading:20960282-Adenoviridae, pubmed-meshheading:20960282-Animals, pubmed-meshheading:20960282-Antibodies, Neutralizing, pubmed-meshheading:20960282-Antibodies, Viral, pubmed-meshheading:20960282-Chiroptera, pubmed-meshheading:20960282-Cross Reactions, pubmed-meshheading:20960282-Female, pubmed-meshheading:20960282-Gene Expression, pubmed-meshheading:20960282-Genetic Vectors, pubmed-meshheading:20960282-HIV, pubmed-meshheading:20960282-Humans, pubmed-meshheading:20960282-Interferon-gamma, pubmed-meshheading:20960282-Interleukin-6, pubmed-meshheading:20960282-Leukocytes, Mononuclear, pubmed-meshheading:20960282-Membrane Glycoproteins, pubmed-meshheading:20960282-Mice, pubmed-meshheading:20960282-Mice, Inbred BALB C, pubmed-meshheading:20960282-Neutralization Tests, pubmed-meshheading:20960282-Recombinant Proteins, pubmed-meshheading:20960282-SARS Virus, pubmed-meshheading:20960282-Viral Envelope Proteins, pubmed-meshheading:20960282-Viral Vaccines
pubmed:year
2010
pubmed:articleTitle
Immunogenicity of the spike glycoprotein of bat SARS-like coronavirus.
pubmed:affiliation
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't